News | April 30, 2021
Dr. Reddy's launches Albendazole tablets in US
Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two
Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two
Sapropterin dihydrochloride powder for oral solution is available in 100 mg unit dose
Dr. Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete by 2pt February 2021.
Fluphenazine Hydrochloride Tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
Dr. Bandichhor brings nearly two decades of experience from Dr. Reddy's Laboratories
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
The product will be marketed by Dr. Reddy's Laboratories Inc.
Subscribe To Our Newsletter & Stay Updated
